<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  
  <url>
    <loc>https://peptidesagora.com/news/082826-samsung-biologics-polypeptide-acquisition-funding</loc>
    <news:news>
      <news:publication>
        <news:name>Peptides Agora</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T18:00:00.000Z</news:publication_date>
      <news:title><![CDATA[Samsung Biologics Prices $2.2B Rights Offering to Close PolyPeptide Acquisition]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://peptidesagora.com/images/articles/samsung-biologics-polypeptide-acquisition-funding.jpg</image:loc>
      <image:title><![CDATA[Samsung Biologics Prices $2.2B Rights Offering to Close PolyPeptide Acquisition]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://peptidesagora.com/news/082726-glutathione-iv-reactions-supplier-lot</loc>
    <news:news>
      <news:publication>
        <news:name>Peptides Agora</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T18:00:00.000Z</news:publication_date>
      <news:title><![CDATA[FDA Trace of 30 IV Glutathione Reactions to Medisca Lot 229536 Exposes Compounding Gap]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://peptidesagora.com/images/articles/glutathione-iv-reactions-supplier-lot.jpg</image:loc>
      <image:title><![CDATA[FDA Trace of 30 IV Glutathione Reactions to Medisca Lot 229536 Exposes Compounding Gap]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://peptidesagora.com/news/082726-retatrutide-early-access-expansion</loc>
    <news:news>
      <news:publication>
        <news:name>Peptides Agora</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T18:00:00.000Z</news:publication_date>
      <news:title><![CDATA[Eli Lilly Expands 'Early Access' to Retatrutide as Black Market Pressure Builds]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://peptidesagora.com/images/articles/retatrutide-early-access-expansion.jpg</image:loc>
      <image:title><![CDATA[Eli Lilly Expands 'Early Access' to Retatrutide as Black Market Pressure Builds]]></image:title>
    </image:image>
  </url>
</urlset>